Status:

COMPLETED

Action-based Cognitive Remediation for First Episode Psychosis

Lead Sponsor:

University of Manitoba

Collaborating Sponsors:

Queen's University

Conditions:

Cognitive Impairment

Psychosis

Eligibility:

All Genders

18-37 years

Phase:

NA

Brief Summary

Cognitive impairments are a core and enduring feature of first-episode psychosis and schizophrenia, and are associated with significant functional impairment. Cognitive remediation (CR) is a behaviour...

Detailed Description

The proposed study will be a two-group randomized control cross-over trial. Participants will be recruited from EPPIS and will be randomly assigned to receive ABCR or treatment-as-usual (TAU) for a pe...

Eligibility Criteria

Inclusion

  • Involved in the Winnipeg Regional Health Authority's Early Psychosis Prevention and Intervention Service
  • Must be at least 18 years old
  • Be proficient in English
  • Have stable medication orders for 3 months
  • Have capacity to voluntarily consent to participate in the treatment study

Exclusion

  • Organic brain damage
  • Intellectual disability

Key Trial Info

Start Date :

February 13 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2019

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT03814122

Start Date

February 13 2019

End Date

November 30 2019

Last Update

January 27 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Crisis Response Centre

Winnipeg, Manitoba, Canada, R3E 0Y1